ADvantage Therapeutics Welcomes Esteemed Expert in Alzheimer’s Disease and Klotho Protein, Carmela Abraham, Ph.D. as Chief Science Officer
02 oct. 2023 10h43 HE
|
Advantage Therapeutics Inc.
ADvantage Therapeutics appoints Dr. Carmela Abraham as Chief Science Officer